Identification of the advanced glycation end products Nε-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis

• Published in: Annals of the rheumatic diseases Vol. 61; no. 6; p. 488
• Main Authors: Drinda, S, Franke, S, Canet, C C, Petrow, P, Bräuer, R, Hüttich, C, Stein, G, Hein, G
• Format: Journal Article
• Language: English
• Published: BMJ Publishing Group Ltd and European League Against Rheumatism 01.06.2002
• Subjects: advanced glycation end products; AGEs; carboxymethyllysine; CML; immunohistochemistry; interleukin; Nε-carboxymethyllysine; osteoarthritis; RAGE; receptor for AGEs; rheumatoid arthritis; synovial tissue; thioredoxin; TNFα; TRX; tumour necrosis factor α
• ISSN: 0003-4967; 1468-2060
• DOI: 10.1136/ard.61.6.488

Background: Generation of advanced glycation end products (AGEs) is an inevitable process in vivo and can be accelerated under pathological conditions such as oxidative stress. In serum and synovial fluid of patients with rheumatoid arthritis (RA) raised AGE levels have been found. Objective: To determine the presence of Nε-carboxymethyllysine (CML; marker of oxidative stress) in RA synovial tissue by immunohistology. Methods: Frozen synovial tissue samples from 10 patients with RA and eight controls (four patients without joint disease and four patients with osteoarthritis (OA)) were treated with rabbit-anti-CML-IgG and goat-antirabbit-IgG. Immunostaining was visualised by streptavidine-alkaline phosphatase (chromogen fuchsin). Cell differentiation was performed with antibodies against CD68, CD45RO, and CD20. Results: CML was detected in the synovial lining, sublining, and endothelium in 10/10 RA and 4/4 OA synovial specimens. In RA some macrophages (CD68+) and T cells (CD45RO+) showed positive immunostaining for CML, whereas B cells were negative. Staining in OA synovial sublining was weak compared with RA. Conclusions: CML was detected for the first time in RA and OA synovial tissue. Different patterns of immunostaining in RA and OA and the presence of CML on macrophages and T cells, suggest a role for CML in the pathogenesis of RA. This might be due to presentation of new epitopes which can maintain or even trigger an autoimmune response.